How should healthtech companies align sales and marketing?

In healthtech, sales and marketing alignment means both teams work from one definition of the target account, one shared view of the buying committee, one set of lead stages with written handoff rules, and one pipeline report. Marketing is judged on revenue-quality pipeline, not lead counts, and sales commits to following up every lead marketing passes over.

Alignment matters more in healthtech than in most software markets. Deals involve several people with different worries. A physician champion cares about workflow. An administrator cares about cost and staffing. IT and security care about data access, hosting and integrations. Compliance cares about privacy and contracts. Finance cares about budget timing. If marketing speaks only to the champion and sales only to the economic buyer, the deal stalls when the security questionnaire arrives.

Misalignment usually shows up in familiar ways:

• Marketing reports rising lead numbers while sales says the leads are poor.
• Sales writes its own decks and one-pagers because marketing's material does not answer buyer questions.
• Nobody can say which channel produced last quarter's closed deals.
• Messaging on the website differs from what reps say on calls.
• Leads sit for days before anyone contacts them.

Each of these has a structural cause, and each can be fixed with a few written agreements and a regular meeting rhythm. The rest of this guide sets those out. For the wider context of selling into care settings, see our guide on how healthtech companies market to medical practices.

Map every role in the typical buying committee, then assign which team creates the material each role needs and who delivers it. Marketing builds the assets and reaches the roles before a call. Sales uses those assets in conversations and reports which questions keep coming up. Both teams update the map after each quarter's win-loss review.

The return-on-investment worksheet is where many teams go wrong. A model filled with assumed savings becomes a claim the buyer may later hold you to. Build the template, but let the buyer enter their own figures, and label every assumption. Where you cite results from existing customers, make sure you have permission, the figures are accurate, and they reflect typical results rather than the best case.

Account-based marketing fits naturally here. For a short list of high-value target accounts, marketing can run targeted ads on LinkedIn, send relevant content to known contacts and support event meetings, while sales leads outreach. Agree in advance which accounts are on the list and who touches them, so a prospect does not receive three uncoordinated messages in one week.

Three sets of rules come up most often: email law for prospecting, federal fraud and abuse law when your product or offer touches care paid for by federal health programs, and privacy law for any patient data in demos or pilots. Marketing and sales should follow one written outreach policy, reviewed by counsel, rather than two separate habits.

Email

The FTC's CAN-SPAM compliance guide states that the law makes no exception for business-to-business email. Commercial emails need accurate header and sender details, honest subject lines, a clear disclosure that the message is an advertisement, a valid physical postal address, a clear way to opt out, and opt-outs honored within 10 business days. That applies to sales sequences as much as to marketing newsletters. A single suppression list shared by both teams avoids the common failure where a prospect opts out of marketing and keeps receiving rep emails.

Gifts, discounts and incentives to providers

The federal Anti-Kickback Statute, summarized by HHS OIG, prohibits knowingly and willfully offering or paying remuneration to induce or reward referrals of items or services paid for by federal health care programs. It reaches both sides of the arrangement. Safe harbors protect some arrangements, but only when every requirement is met. If your product generates or influences billable services, have counsel review free trials, revenue-sharing, referral fees, event sponsorships and gifts before sales or marketing offers them.

Patient data in demos and pilots

Demos should use synthetic data. If a pilot involves protected health information, a BAA and security review should be in place before any data moves. Phone and text outreach brings in its own consent rules, so confirm those with counsel before running calling or SMS campaigns.

One senior person should own the combined revenue plan, with authority over both marketing priorities and the handoff rules. In a small healthtech company that is often the CEO or a commercial co-founder at first. As the team grows, a dedicated marketing leader, sometimes part-time, usually takes over the marketing side and co-owns the shared metrics with the sales lead.

Signs it is time for dedicated marketing leadership include founders spending more time on campaign decisions than on customers, agencies and freelancers working without a single brief, and no one able to explain pipeline by source. A full-time hire can be premature at this stage. A fractional CMO can set the lead definitions, write the service-level agreement, run the monthly review and oversee outside vendors.

At Ichelon Consulting US, Santosh Reddy, Partner, serves as fractional CMO for healthcare companies. Plans run from $1,000 a month for Advisory to $1,500 a month for Growth, which adds agency and vendor oversight and a monthly board-ready marketing report, and $2,000 a month for Embedded, which adds weekly sessions and leadership of the in-house marketing team. Execution work is scoped separately. See the fractional CMO for healthcare companies page, compare it with hiring an agency, or book a call to talk through your current handoff process.